The role of sclerotherapy as a medical treatment beyond cosmetic uses
Abstract
Sclerotherapy is the treatment of choice for telangiectasia and reticular veins and represents a useful alternative to other procedures for varicose veins and incompetent perforating veins. Nevertheless, sclerotherapy is often mistaken for a cosmetic and aesthetical treatment, because of a widespread misinformation. Sclerotherapy is not an aesthetic treatment, because it applies to varicose veins, reticular veins and telangiectasia, which are expressions of chronic venous disease. according to CEAP classification. Fort this reason, it is important to educate the patient about the underlying pathology and clarify the benefits and possible complications of sclerotherapy.
Keywords
References
- 1. Barabino N. Sclerotherapy of great saphenous vein: a state-of-the-art review and new perspectives. Veins and Lymphatics 2025;14:13682. DOI: https://doi.org/10.4081/vl.2025.13682
- 2. Diamond C, Quinn AP, Presley CL, et al. Telangiectasia-related social media posts: cross-sectional analysis of TikTok and Instagram. JMIR Dermatol 2023:6:e41716. DOI: https://doi.org/10.2196/41716
- 3. World Medical Association (WMA). Statement on aesthetic treatment. Available from: https://www.wma.net/policies-post/wma-statement-on-aesthetic-treatment/
- 4. Rabe E, Pannier F. Clinical, etiological, anatomical and pathological classification (CEAP): gold standard and limits. Phlebology 2012:114-8. DOI: https://doi.org/10.1258/phleb.2012.012s19
- 5. Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007;26:22-8. DOI: https://doi.org/10.1016/j.sder.2006.12.009
- 6. Associazione Flebologica Italiana (AFI). Consenso Informato. Available from: https://www.associazioneflebologicaitaliana.it/consenso-informato.html
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2026 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.